Vir Biotechnology Inc. (VIR) Announces CTO Departure

On January 24, 2025, Vir Biotechnology Inc. (NASDAQ: VIR) announced that Ann (Aine) M. Hanly, Ph.D., the Company’s Executive Vice President and Chief Technology Officer, will be leaving the Company on February 26, 2025. The Company has appointed Maninder Hora, Ph.D. to the role of Executive Vice President and Chief Technical Operations Officer, effective February 27, 2025, and Dr. Hora will assume Dr. Hanly’s responsibilities.

You May Also Be Interested In

• Wendy's names former McDonald's executive as new marketing chief
• Cyabra wins two European government security contracts worth $500K
• Afya confirms early-stage merger talks with Yduqs